2022 Hyundai Ioniq 5 Limited
4×4 • AT
KM8KRDAF0NU064818
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
4×4 • AT
Odometer
33,472 mi ≈ 53,868 km
Primary damage
Side
Secondary damage
Rear end
Docs
PA • Salvage
Extra
Auction
VIN
KM8KRDAF0NU064818
Lot number
59525895
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Philadelphia East-sublot, PA
Description
Fuel type
Electric
Body color
Black
Body type
SUV
Trim
Limited
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Ioniq 5 Limited • 4×4 • Automatic • Copart Lot: 59525895 • VIN: KM8KRDAF0NU064818
Find out more about this 2022 Hyundai Ioniq 5 Limited, available at the Copart salvage car auction as lot #59525895 in Philadelphia East-sublot, PA. This car has Side main damage. It is listed with Run and drive start condition code. Odometer shows 33,472 mi. This Black Hyundai Ioniq 5 SUV is equipped with Electric engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for KM8KRDAF0NU064818 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
